World Health Organization Expresses Deep Regret Over United States Withdrawal Notice and Defends Pandemic Record

The World Health Organization (WHO) has formally expressed profound regret following the decision by the United States government to notify the international community of its withdrawal from the global health body. As a founding member state that helped draft the WHO Constitution in 1948, the United States has historically provided substantial financial, scientific, and operational support. This partnership has underpinned numerous monumental achievements in international public health over the past three quarters of a century. However, the current administration’s notification has initiated a formal departure process that threatens to fracture global health security architectures at a time when collaborative disease surveillance is widely considered vital.

The unfolding diplomatic and institutional crisis brings to the forefront longstanding tensions regarding multilateral governance, pandemic accountability, and the financing of international health agencies. The formal notification sets in motion a series of procedural milestones within the United Nations specialized agency. The WHO Executive Board is scheduled to review the legal, financial, and operational implications of the U.S. notification during its regular session, followed by a broader debate and decision-making process at the annual World Health Assembly.

Historical Context and Contributions of the United States

To understand the weight of the current rupture, it is necessary to examine the deeply embedded role the United States has played within the architecture of the World Health Organization. Since the inception of the agency, American scientists, public health officials, and philanthropic organizations have worked hand-in-hand with international counterparts. U.S. funding and epidemiological expertise were instrumental in the historic eradication of smallpox, declared in 1980 after a decade-long intensive global vaccination campaign.

Furthermore, American contributions have been pivotal in the ongoing global fight against poliomyelitis, bringing the world to the brink of total eradication. U.S. agencies such as the Centers for Disease Control and Prevention (CDC) have routinely collaborated with WHO field offices to combat high-consequence pathogens, including Ebola virus disease in West and Central Africa, recurring influenza pandemics, drug-resistant tuberculosis, and endemic malaria. The withdrawal of Washington from this framework not only creates a massive budgetary shortfall—given that the U.S. has traditionally been the organization’s single largest state donor—but also deprives the global network of specialized technical expertise and surveillance data sharing that the CDC and other American institutions routinely provide.

The Catalyst: U.S. Allegations and the WHO Defense

The formal notification of withdrawal issued by Washington cites multiple grievances, chief among them being alleged systemic failures by the WHO during the critical early phases of the COVID-19 pandemic. Specifically, the U.S. government asserted that the organization obstructed the timely and accurate sharing of critical epidemiological information and subsequently attempted to obscure those missteps.

In its official response, the leadership of the WHO has pushed back vigorously against these accusations. While acknowledging that no government or international organization executed a flawless response to an unprecedented global crisis, the agency defends its performance, insisting it operated with transparency, speed, and strict adherence to available scientific evidence.

The WHO maintains that throughout the pandemic, it consistently recommended evidence-based public health interventions such as mask-wearing, vaccination, and physical distancing, while pointedly avoiding prescriptive mandates regarding lockdowns or compulsory medical interventions. Agency officials emphasize that operational and regulatory decisions remained firmly in the hands of sovereign national governments, which utilized WHO guidance to tailor policies to their domestic populations.

Chronology of the Early COVID-19 Response

The timeline of the WHO’s actions during the emergence of SARS-CoV-2 remains a central point of contention and defense. A detailed examination of the early weeks of the outbreak reveals the following sequence of events:

• December 31, 2019: The WHO country office in China picked up a media statement from the Wuhan Municipal Health Commission concerning cases of "viral pneumonia." Later that same day, the WHO’s Epidemic Intelligence and Response system formally requested official information from Chinese authorities regarding the cluster of atypical pneumonia cases.
• January 1, 2020: The WHO activated its Incident Management Support Team at its headquarters, regional offices, and country offices, placing the organization on an emergency footing.
• January 5, 2020: The WHO published its first Disease Outbreak News report, disseminating technical information to all Member States regarding the novel cluster of pneumonia cases in Wuhan, including risk assessment and advice on public health measures.
• January 10–11, 2020: Comprehensive technical guidance packages were issued to all global member countries detailing how to detect, test, and manage potential cases. On January 11, China officially reported the world’s first known death linked to the novel virus.
• January 30, 2020: WHO Director-General Dr. Tedros Adhanom Ghebreyesus convened the Emergency Committee under the International Health Regulations (IHR). Following their advice, he declared the outbreak a Public Health Emergency of International Concern (PHEIC)—the highest level of alarm under international law. At the time of this declaration, fewer than 100 cases and zero deaths had been officially reported outside of China.
• February and March 2020: As cases multiplied across Europe, the Middle East, and North America, the Director-General repeatedly cautioned world leaders that the global window of opportunity to contain the pathogen was rapidly narrowing, famously characterizing the situation by stating, "This is not a drill."

Addressing Accusations of Politisation and Bureaucracy

Beyond the specific handling of the coronavirus crisis, the United States statement accused the organization of pursuing a politicized, bureaucratic agenda influenced by member nations whose interests run counter to those of the United States.

The WHO has categorically rejected these characterizations, pointing to its governance structure as a specialized United Nations agency accountable to 194 distinct Member States. The organization asserts that its operational mandate requires absolute impartiality, functioning without fear or favor to serve populations across ideological and geopolitical divides. Officials argue that international health security is inherently indivisible; pathogens do not respect national borders or geopolitical alignments, making multilateral cooperation a fundamental necessity rather than a political preference.

Implications for Global Health Security and the Pandemic Agreement

The impending departure of the United States carries profound structural and financial implications for global health governance. Financially, the loss of assessed and voluntary contributions from Washington poses a significant challenge to the WHO’s operational budget, potentially impacting disease surveillance programs in fragile states, immunization drives in developing nations, and emergency response deployments.

At the same time, the international community continues to press forward with institutional reforms designed to prevent future global health catastrophes. In a major milestone reached prior to the U.S. announcement, WHO Member States adopted the landmark WHO Pandemic Agreement. This international legal instrument aims to establish binding commitments among nations to enhance prevention, preparedness, and response capacities.

Currently, Member States are actively negotiating an accompanying annex known as the Pathogen Access and Benefit Sharing (PABS) system. If successfully ratified and implemented, the PABS system is designed to streamline the rapid detection and sharing of emergent pathogens with pandemic potential, while simultaneously guaranteeing equitable, timely access to life-saving vaccines, therapeutics, and diagnostics for all participating countries, regardless of economic status.

Path Forward and Future Outlook

Despite the diplomatic friction and the procedural steps toward American withdrawal, the leadership of the World Health Organization has maintained an open door, expressing a strong desire that the United States will eventually reconsider its stance and return to active participation within the multilateral body.

In the interim, the organization remains steadfastly focused on executing its core constitutional mandate: the attainment by all peoples of the highest possible level of health. As the WHO Executive Board and the World Health Assembly prepare to debate the legal and operational ramifications of the notification, the global public health community watches closely, cognizant that the future stability of international disease control relies heavily on bridging political divides to confront shared biological threats.